Introgen Therapeutics, Inc. (INGN) Earnings
|
Expand Research on INGN
| Next EPS Date | 8/12/26 | EPS Growth Rate | -13.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.7% | Revenue Growth Rate | +3.0% |
| Average % Move 1-Wk after EPS | +4.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.17 | N/A | N/A | $95.05M | = | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.30 | -$0.29 | -$0.01 | $85.1M | $82.35M | = |  | | Details | |
| 2/24/26 | Q425 | -$0.26 | -$0.33 | +$0.07 | $81.7M | $88.6M | = | | | Details | |
| 11/5/25 | Q325 | -$0.20 | -$0.21 | +$0.01 | $92.39M | $93.27M | = | | | Details | |
| 8/7/25 | Q225 | -$0.15 | -$0.27 | +$0.12 | $92.28M | $90.5M | = | | | Details | |
| 5/7/25 | Q125 | -$0.11 | -$0.47 | +$0.36 | $82.3M | $79M | = | | | Details | |
| 2/25/25 | Q424 | -$0.41 | -$0.61 | +$0.20 | $80.08M | $73.9M | = | | | Details | |
| 11/7/24 | Q324 | -$0.25 | -$0.50 | +$0.25 | $88.8M | $84.14M | = | | | Details |
